Advancing VR-based Attentional Bias as a Biomarker for Tobacco Use Disorder

NCT06582888 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Nicotine Addiction
Craving

Interventions

DRUG: Varenicline Tartrate
DRUG: Placebo

Sponsor

University of California, San Diego

Collaborators

[object Object]